Variant report
Variant | esv3380164 |
---|---|
Chromosome Location | chr5:28945595-28949493 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs571909756 | chr5:28945604-28945605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs141213288 | chr5:28945652-28945653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560626343 | chr5:28945677-28945678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575765803 | chr5:28945711-28945712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544390983 | chr5:28945716-28945717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs77869645 | chr5:28945758-28945759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs556893853 | chr5:28945823-28945824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs3050790 | chr5:28945825-28945826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs35372711 | chr5:28945826-28945827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533576266 | chr5:28945860-28945861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs545338110 | chr5:28945866-28945867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs377071582 | chr5:28945907-28945908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560857112 | chr5:28945924-28945925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs314795 | chr5:28945926-28945927 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs549428641 | chr5:28945960-28945961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs146949904 | chr5:28945988-28945989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs73747120 | chr5:28946070-28946071 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs578220688 | chr5:28946131-28946132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs531884242 | chr5:28946136-28946137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573443923 | chr5:28946179-28946180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571312058 | chr5:28946185-28946186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs542812499 | chr5:28946197-28946198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553754575 | chr5:28946252-28946253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs539194960 | chr5:28946293-28946294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs137922484 | chr5:28946315-28946316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535828913 | chr5:28946324-28946325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs160608 | chr5:28946329-28946330 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs571035937 | chr5:28946347-28946348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540940824 | chr5:28946359-28946360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs112794564 | chr5:28946405-28946406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs190664946 | chr5:28946417-28946418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs578086597 | chr5:28946418-28946419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs545607724 | chr5:28946461-28946462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs560603326 | chr5:28946469-28946470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs528028595 | chr5:28946496-28946497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs543037486 | chr5:28946501-28946502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs312659 | chr5:28946519-28946520 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs531744145 | chr5:28946528-28946529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs549970813 | chr5:28946572-28946573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs181518678 | chr5:28946608-28946609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs75780830 | chr5:28946688-28946689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs550364924 | chr5:28946723-28946724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184408681 | chr5:28946733-28946734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs570274557 | chr5:28946773-28946774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs565826603 | chr5:28946787-28946788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs386686658 | chr5:28946788-28946789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs312657 | chr5:28946796-28946797 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs569270122 | chr5:28946890-28946891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs536664839 | chr5:28946931-28946932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs372463813 | chr5:28946933-28946934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:28935000-28958800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |